Literature DB >> 33178865

Importance of CNOT8 Deadenylase Subunit in DNA Damage Responses Following Ionizing Radiation (IR).

Samira Eskandarian1,2, Roger Grand2, Shiva Irani1, Mohsen Saeedi3, Reza Mirfakhraie4.   

Abstract

BACKGROUND: The Ccr4-Not protein complex (CNOT complex) is a key regulator of gene expression in eukaryotic cells. Ccr4-Not Complex is composed of at least nine conserved subunits in mammalian cells with two main enzymatic activities. CNOT8 is a subunit of the complex with deadenylase activity that interacts transiently with the CNOT6 or CNOT6L subunits. Here, we focused on the role of the human CNOT8 subunit in the DNA damage response (DDR).
METHODS: Cell viability was assessed to measure ATP level using a Cell Titer-Glo Luminescence reagent up to 4 days' post CNOT8 siRNA transfection. In addition, expression level of phosphorylated proteins in signalling pathways were detected by western blotting and immunofluorescence microscopy. CNOT8- depleted Hela cells post- 3 Gy ionizing radiation (IR) treatment were considered as a control.
RESULTS: Our results from cell viability assays indicated a significant reduction at 72-hour post CNOT8 siRNA transfection (p= 0.04). Western blot analysis showed slightly alteration in the phosphorylation of DNA damage response (DDR) proteins in CNOT8-depleted HeLa cells following treatment with ionizing radiation (IR). Increased foci formation of γH2AX, RPA, 53BP1, and RAD51 foci was observed after IR in CNOT8-depleted cells compared to the control cells.
CONCLUSION: We conclude that CNOT8 deadenylase subunit is involved in the cellular response to DNA damage.

Entities:  

Keywords:  CNOT complex; CNOT8; DNA damage response; SiRNA

Year:  2020        PMID: 33178865      PMCID: PMC7603255          DOI: 10.29252/rbmb.9.2.163

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  34 in total

1.  Many faces of ATM: eighth international workshop on ataxia-telangiectasia.

Authors:  T D Halazonetis; Y Shiloh
Journal:  Biochim Biophys Acta       Date:  1999-10-29

Review 2.  The structural basis for deadenylation by the CCR4-NOT complex.

Authors:  Mark Bartlam; Tadashi Yamamoto
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

Review 3.  The control of DNA repair by the cell cycle.

Authors:  Nicole Hustedt; Daniel Durocher
Journal:  Nat Cell Biol       Date:  2016-12-23       Impact factor: 28.824

Review 4.  Ccr4-Not complex: the control freak of eukaryotic cells.

Authors:  Jason E Miller; Joseph C Reese
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-03-15       Impact factor: 8.250

5.  DNA double-strand break formation upon UV-induced replication stress activates ATM and DNA-PKcs kinases.

Authors:  Hirohiko Yajima; Kyung-Jong Lee; Shichuan Zhang; Junya Kobayashi; Benjamin P C Chen
Journal:  J Mol Biol       Date:  2008-11-27       Impact factor: 5.469

6.  Caf1 regulates translocation of ribonucleotide reductase by releasing nucleoplasmic Spd1-Suc22 assembly.

Authors:  Shinya Takahashi; Kenji Kontani; Yasuhiro Araki; Toshiaki Katada
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

Review 7.  The role of the E3 ligase Not4 in cotranslational quality control.

Authors:  Olesya O Panasenko
Journal:  Front Genet       Date:  2014-05-19       Impact factor: 4.599

8.  The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.

Authors:  Maryati Maryati; Blessing Airhihen; G Sebastiaan Winkler
Journal:  Biochem J       Date:  2015-05-06       Impact factor: 3.857

9.  Persistent DNA Damage Foci and DNA Replication with a Broken Chromosome in the African Trypanosome.

Authors:  Lucy Glover; Catarina A Marques; Olga Suska; David Horn
Journal:  mBio       Date:  2019-07-09       Impact factor: 7.867

10.  RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Authors:  C Cruz; M Castroviejo-Bermejo; S Gutiérrez-Enríquez; A Llop-Guevara; Y H Ibrahim; A Gris-Oliver; S Bonache; B Morancho; A Bruna; O M Rueda; Z Lai; U M Polanska; G N Jones; P Kristel; L de Bustos; M Guzman; O Rodríguez; J Grueso; G Montalban; G Caratú; F Mancuso; R Fasani; J Jiménez; W J Howat; B Dougherty; A Vivancos; P Nuciforo; X Serres-Créixams; I T Rubio; A Oaknin; E Cadogan; J C Barrett; C Caldas; J Baselga; C Saura; J Cortés; J Arribas; J Jonkers; O Díez; M J O'Connor; J Balmaña; V Serra
Journal:  Ann Oncol       Date:  2018-05-01       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.